Angiodynamic Inc (ANGO)

NASD · Healthcare · Medical Instruments & Supplies · USA

Angiodynamic Inc is a small cap company (market value between $300 million and $2 billion) in the Medical Instruments & Supplies industry.

AngioDynamic Inc designs, manufactures and sells medical devices for treating cardiovascular disease and cancer. The company operates two segments: Med Tech, featuring the Auryon Atherectomy System, thrombectomy devices, thrombolytic catheters and NanoKnife ablation system; and Med Device, offering angiographic catheters, guidewires, drainage catheters and central venous access ports.

From its FY2026 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Angiodynamic Inc stock.

Our verdict on ANGO

Overvalued: intrinsic value $9.22 per share, market price $11.49, margin of safety -24.6% (as of 2026-11-17).

A 1.1x revenue multiple, discounted for its losses, values the shares at $9.22; the price of $11.49 is 25% above that value.

ETFs with the most weight in ANGO

17 more funds hold it; the full list is part of the paid plan.

More on ANGO

Browse

Peers in Medical Instruments & Supplies

All 52 Medical Instruments & Supplies stocks

Cheaper than ANGO in Medical Instruments & Supplies

5 more in this industry show a wider margin of safety.

Is ANGO undervalued or overvalued?

ANGO is overvalued (as of the 2026-11-17 close). A 1.1x revenue multiple, discounted for its losses, values the shares at $9.22; the price of $11.49 is 25% above that value.

What is the intrinsic value of ANGO?

$9.22 per share (as of the 2026-11-17 close), against a market price of $11.49. That is a margin of safety of -24.6%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.